Characteristics of Hydroxychloroquine Dispensing in the United States, January to May 2020.

Levin, Zachary; Chang, Jessica; Karaca-Mandic, Pinar; Duarte-García, Alí; Jeffery, Molly Moore

Levin, Zachary; Chang, Jessica; Karaca-Mandic, Pinar; Duarte-García, Alí; Jeffery, Molly Moore.

Levin Z; University of Minnesota School of Public Health, Minneapolis, MN, USA.
Chang J; University of Minnesota School of Public Health, Minneapolis, MN, USA.
Karaca-Mandic P; Carlson School of Management, University of Minnesota, Minneapolis, MN, USA.
Duarte-García A; Division of Rheumatology, Mayo Clinic, Rochester, MN, USA.
Jeffery MM; Division of Health Care Delivery Research and Department of Emergency Medicine, Mayo Clinic, Rochester, MN, USA. jeffery.molly@mayo.edu.

J Gen Intern Med ; 37(1): 176-178, 2022 01.

Article in English | MEDLINE | ID: covidwho-1616225

Subject(s)

Hydroxychloroquine; Humans; United States/epidemiology

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Hydroxychloroquine Type of study: Observational study Limits: Humans Country/Region as subject: North America Language: English Journal: J Gen Intern Med Journal subject: Internal Medicine Year: 2022 Document Type: Article Affiliation country: S11606-021-07175-9

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google